St. Jude Clinical Trials
-
COVID-19 Pediatric Vaccine Studies
St. Jude is planning to participate in clinical trials to test COVID-19 prevention vaccines in healthy children. Find out more.
-
REDIRECTED - COVID-19 Vaccine Study ENSEMBLE
St. Jude and UTHSC conducted trials in Memphis for a COVID prevention vaccine for adults. Read about the trial and its early results.
SENDAI: A Phase I Study of Unmodified Live Intranasal Sendai Virus Vaccine in Children and Toddlers: Assessment of Safety and Immunogenicity
Eligibility:
- Child is greater than or equal to twelve (12) months and less than twenty-four (24) months.
- Child has adequate blood, liver and kidney function.
- Child has no history of lung disease, asthma, and hospitalization for respiratory illness, immunodeficiency, sickle cell disease, or any other serious underlying condition.